海正生材10月13日获融资买入481.67万元，融资余额7054.91万元

Group 1 - The core viewpoint of the news is that Zhejiang Haizheng Biomaterials Co., Ltd. is experiencing significant fluctuations in its stock performance and financial metrics, indicating potential investment opportunities and risks [1][2]. Group 2 - On October 13, Haizheng Biomaterials' stock fell by 2.05%, with a trading volume of 42.91 million yuan. The financing data shows a net financing buy of -2.79 million yuan for the day, with a total financing balance of 70.55 million yuan, accounting for 4.10% of the circulating market value [1]. - As of June 30, the number of shareholders increased by 11.75% to 7,457, while the average circulating shares per person decreased by 10.51% to 15,787 shares. For the first half of 2025, the company reported a revenue of 408 million yuan, a year-on-year decrease of 5.28%, and a net profit attributable to shareholders of 3.18 million yuan, down 87.32% year-on-year [2]. - The company has cumulatively distributed dividends of 42.49 million yuan since its A-share listing, and as of June 30, 2025, the fifth largest circulating shareholder is Guangfa Technology Innovation Mixed A, holding 7.05 million shares as a new shareholder [2].